nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CYP2C18—malignant glioma	0.193	0.288	CbGaD
Diclofenac—CXCL8—malignant glioma	0.184	0.276	CbGaD
Diclofenac—CYP2B6—malignant glioma	0.143	0.214	CbGaD
Diclofenac—PTGS1—malignant glioma	0.094	0.141	CbGaD
Diclofenac—PTGS2—malignant glioma	0.0537	0.0805	CbGaD
Diclofenac—CYP1A2—Carmustine—malignant glioma	0.0311	0.57	CbGbCtD
Diclofenac—CYP3A4—Temozolomide—malignant glioma	0.0235	0.431	CbGbCtD
Diclofenac—TTR—choroid plexus—malignant glioma	0.0107	0.155	CbGeAlD
Diclofenac—SLC22A8—choroid plexus—malignant glioma	0.00658	0.0953	CbGeAlD
Diclofenac—TTR—vertebral column—malignant glioma	0.00379	0.0549	CbGeAlD
Diclofenac—TTR—pineal body—malignant glioma	0.00273	0.0395	CbGeAlD
Diclofenac—Meningitis—Carmustine—malignant glioma	0.00167	0.0196	CcSEcCtD
Diclofenac—ASIC1—telencephalon—malignant glioma	0.00166	0.024	CbGeAlD
Diclofenac—KCNQ2—brainstem—malignant glioma	0.00137	0.0198	CbGeAlD
Diclofenac—KCNQ3—telencephalon—malignant glioma	0.00132	0.0191	CbGeAlD
Diclofenac—ASIC1—medulla oblongata—malignant glioma	0.0013	0.0189	CbGeAlD
Diclofenac—KCNQ2—telencephalon—malignant glioma	0.00121	0.0176	CbGeAlD
Diclofenac—Azotaemia—Carmustine—malignant glioma	0.00121	0.0143	CcSEcCtD
Diclofenac—ASIC1—midbrain—malignant glioma	0.00119	0.0173	CbGeAlD
Diclofenac—ASIC1—spinal cord—malignant glioma	0.00116	0.0168	CbGeAlD
Diclofenac—Transaminases increased—Carmustine—malignant glioma	0.00106	0.0125	CcSEcCtD
Diclofenac—Cerebration impaired—Temozolomide—malignant glioma	0.00106	0.0125	CcSEcCtD
Diclofenac—Haemorrhoids—Temozolomide—malignant glioma	0.00106	0.0125	CcSEcCtD
Diclofenac—KCNQ3—medulla oblongata—malignant glioma	0.00104	0.015	CbGeAlD
Diclofenac—Myasthenia—Carmustine—malignant glioma	0.00103	0.0121	CcSEcCtD
Diclofenac—Encephalopathy—Carmustine—malignant glioma	0.00101	0.0119	CcSEcCtD
Diclofenac—PLA2G2A—telencephalon—malignant glioma	0.001	0.0145	CbGeAlD
Diclofenac—Aphasia—Carmustine—malignant glioma	0.000996	0.0117	CcSEcCtD
Diclofenac—Aphasia—Temozolomide—malignant glioma	0.000962	0.0113	CcSEcCtD
Diclofenac—Hypokinesia—Carmustine—malignant glioma	0.000957	0.0113	CcSEcCtD
Diclofenac—KCNQ3—midbrain—malignant glioma	0.000948	0.0137	CbGeAlD
Diclofenac—ASIC1—central nervous system—malignant glioma	0.000943	0.0137	CbGeAlD
Diclofenac—Burning sensation—Carmustine—malignant glioma	0.00093	0.0109	CcSEcCtD
Diclofenac—TTR—embryo—malignant glioma	0.000928	0.0134	CbGeAlD
Diclofenac—ASIC1—cerebellum—malignant glioma	0.000922	0.0134	CbGeAlD
Diclofenac—TTR—brainstem—malignant glioma	0.000851	0.0123	CbGeAlD
Diclofenac—Scotoma—Carmustine—malignant glioma	0.000851	0.01	CcSEcCtD
Diclofenac—SLCO1C1—telencephalon—malignant glioma	0.000845	0.0122	CbGeAlD
Diclofenac—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000843	0.00993	CcSEcCtD
Diclofenac—Scotoma—Temozolomide—malignant glioma	0.000822	0.00968	CcSEcCtD
Diclofenac—TTR—retina—malignant glioma	0.000821	0.0119	CbGeAlD
Diclofenac—Hyperaesthesia—Temozolomide—malignant glioma	0.000795	0.00937	CcSEcCtD
Diclofenac—Memory impairment—Temozolomide—malignant glioma	0.000795	0.00937	CcSEcCtD
Diclofenac—Injection site pain—Carmustine—malignant glioma	0.000791	0.00932	CcSEcCtD
Diclofenac—CXCL8—medulla oblongata—malignant glioma	0.000778	0.0113	CbGeAlD
Diclofenac—TTR—telencephalon—malignant glioma	0.000755	0.0109	CbGeAlD
Diclofenac—Speech disorder—Carmustine—malignant glioma	0.000751	0.00884	CcSEcCtD
Diclofenac—KCNQ3—central nervous system—malignant glioma	0.00075	0.0109	CbGeAlD
Diclofenac—ASIC1—brain—malignant glioma	0.000749	0.0108	CbGeAlD
Diclofenac—KCNQ3—cerebellum—malignant glioma	0.000733	0.0106	CbGeAlD
Diclofenac—Accidental injury—Carmustine—malignant glioma	0.00073	0.0086	CcSEcCtD
Diclofenac—Speech disorder—Temozolomide—malignant glioma	0.000726	0.00855	CcSEcCtD
Diclofenac—Disturbance in attention—Temozolomide—malignant glioma	0.000721	0.00849	CcSEcCtD
Diclofenac—PLA2G2A—midbrain—malignant glioma	0.000718	0.0104	CbGeAlD
Diclofenac—CXCL8—midbrain—malignant glioma	0.000711	0.0103	CbGeAlD
Diclofenac—Thinking abnormal—Carmustine—malignant glioma	0.000706	0.00831	CcSEcCtD
Diclofenac—CXCL8—spinal cord—malignant glioma	0.000694	0.01	CbGeAlD
Diclofenac—Viral infection—Temozolomide—malignant glioma	0.000691	0.00814	CcSEcCtD
Diclofenac—KCNQ2—central nervous system—malignant glioma	0.00069	0.01	CbGeAlD
Diclofenac—Bromfenac—PTGS1—malignant glioma	0.000683	0.166	CrCbGaD
Diclofenac—Herpes simplex—Temozolomide—malignant glioma	0.000677	0.00798	CcSEcCtD
Diclofenac—KCNQ2—cerebellum—malignant glioma	0.000675	0.00977	CbGeAlD
Diclofenac—Gait disturbance—Carmustine—malignant glioma	0.000662	0.00779	CcSEcCtD
Diclofenac—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00066	0.00777	CcSEcCtD
Diclofenac—Coordination abnormal—Carmustine—malignant glioma	0.000658	0.00775	CcSEcCtD
Diclofenac—Hearing impaired—Temozolomide—malignant glioma	0.000656	0.00772	CcSEcCtD
Diclofenac—Neck pain—Carmustine—malignant glioma	0.000654	0.0077	CcSEcCtD
Diclofenac—Injection site reaction—Carmustine—malignant glioma	0.000642	0.00756	CcSEcCtD
Diclofenac—Gait disturbance—Temozolomide—malignant glioma	0.00064	0.00753	CcSEcCtD
Diclofenac—Coordination abnormal—Temozolomide—malignant glioma	0.000636	0.00749	CcSEcCtD
Diclofenac—Skin exfoliation—Carmustine—malignant glioma	0.000617	0.00726	CcSEcCtD
Diclofenac—PTGS1—endothelium—malignant glioma	0.000614	0.00889	CbGeAlD
Diclofenac—SLCO1C1—midbrain—malignant glioma	0.000607	0.00879	CbGeAlD
Diclofenac—Skin exfoliation—Temozolomide—malignant glioma	0.000596	0.00702	CcSEcCtD
Diclofenac—KCNQ3—brain—malignant glioma	0.000595	0.00863	CbGeAlD
Diclofenac—TTR—medulla oblongata—malignant glioma	0.000593	0.00859	CbGeAlD
Diclofenac—SLCO1C1—spinal cord—malignant glioma	0.000592	0.00857	CbGeAlD
Diclofenac—Coma—Carmustine—malignant glioma	0.00059	0.00695	CcSEcCtD
Diclofenac—PTGS2—endothelium—malignant glioma	0.000587	0.0085	CbGeAlD
Diclofenac—Aplastic anaemia—Temozolomide—malignant glioma	0.000586	0.0069	CcSEcCtD
Diclofenac—Lumiracoxib—PTGS1—malignant glioma	0.000581	0.141	CrCbGaD
Diclofenac—PLA2G2A—central nervous system—malignant glioma	0.000568	0.00823	CbGeAlD
Diclofenac—PTGS1—blood vessel—malignant glioma	0.000566	0.0082	CbGeAlD
Diclofenac—Abnormal vision—Carmustine—malignant glioma	0.000563	0.00663	CcSEcCtD
Diclofenac—Mental disability—Carmustine—malignant glioma	0.000561	0.0066	CcSEcCtD
Diclofenac—Sepsis—Carmustine—malignant glioma	0.000561	0.0066	CcSEcCtD
Diclofenac—Nepafenac—PTGS1—malignant glioma	0.000553	0.134	CrCbGaD
Diclofenac—CXCL8—cerebellum—malignant glioma	0.00055	0.00797	CbGeAlD
Diclofenac—KCNQ2—brain—malignant glioma	0.000548	0.00794	CbGeAlD
Diclofenac—Abnormal vision—Temozolomide—malignant glioma	0.000544	0.00641	CcSEcCtD
Diclofenac—Phlebitis—Carmustine—malignant glioma	0.000544	0.00641	CcSEcCtD
Diclofenac—TTR—midbrain—malignant glioma	0.000542	0.00785	CbGeAlD
Diclofenac—Mental disability—Temozolomide—malignant glioma	0.000542	0.00638	CcSEcCtD
Diclofenac—PTGS2—blood vessel—malignant glioma	0.000541	0.00784	CbGeAlD
Diclofenac—Swelling—Carmustine—malignant glioma	0.000532	0.00626	CcSEcCtD
Diclofenac—Ear pain—Temozolomide—malignant glioma	0.000531	0.00625	CcSEcCtD
Diclofenac—TTR—spinal cord—malignant glioma	0.000529	0.00766	CbGeAlD
Diclofenac—Eye pain—Carmustine—malignant glioma	0.000519	0.00612	CcSEcCtD
Diclofenac—Gastroenteritis—Temozolomide—malignant glioma	0.000511	0.00602	CcSEcCtD
Diclofenac—Injury—Carmustine—malignant glioma	0.00051	0.00601	CcSEcCtD
Diclofenac—Deafness—Temozolomide—malignant glioma	0.000507	0.00597	CcSEcCtD
Diclofenac—Vascular purpura—Temozolomide—malignant glioma	0.000507	0.00597	CcSEcCtD
Diclofenac—Hepatic failure—Temozolomide—malignant glioma	0.000504	0.00594	CcSEcCtD
Diclofenac—Eye pain—Temozolomide—malignant glioma	0.000502	0.00591	CcSEcCtD
Diclofenac—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00048	0.00566	CcSEcCtD
Diclofenac—SLCO1C1—central nervous system—malignant glioma	0.00048	0.00695	CbGeAlD
Diclofenac—Thirst—Temozolomide—malignant glioma	0.000476	0.00561	CcSEcCtD
Diclofenac—Purpura—Temozolomide—malignant glioma	0.00047	0.00554	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000469	0.00552	CcSEcCtD
Diclofenac—Diplopia—Carmustine—malignant glioma	0.000469	0.00552	CcSEcCtD
Diclofenac—Diplopia—Temozolomide—malignant glioma	0.000453	0.00534	CcSEcCtD
Diclofenac—Face oedema—Carmustine—malignant glioma	0.000453	0.00533	CcSEcCtD
Diclofenac—Meclofenamic acid—PTGS1—malignant glioma	0.000453	0.11	CrCbGaD
Diclofenac—PLA2G2A—brain—malignant glioma	0.000451	0.00654	CbGeAlD
Diclofenac—CXCL8—brain—malignant glioma	0.000447	0.00647	CbGeAlD
Diclofenac—SCN4A—central nervous system—malignant glioma	0.000441	0.00639	CbGeAlD
Diclofenac—Face oedema—Temozolomide—malignant glioma	0.000437	0.00515	CcSEcCtD
Diclofenac—TTR—central nervous system—malignant glioma	0.000429	0.00622	CbGeAlD
Diclofenac—TTR—cerebellum—malignant glioma	0.000419	0.00608	CbGeAlD
Diclofenac—Dry skin—Temozolomide—malignant glioma	0.000415	0.00489	CcSEcCtD
Diclofenac—Muscular weakness—Carmustine—malignant glioma	0.000414	0.00487	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000408	0.00481	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000408	0.00481	CcSEcCtD
Diclofenac—Muscular weakness—Temozolomide—malignant glioma	0.0004	0.00471	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.0004	0.00471	CcSEcCtD
Diclofenac—ABCC1—telencephalon—malignant glioma	0.000398	0.00576	CbGeAlD
Diclofenac—Abdominal distension—Temozolomide—malignant glioma	0.000394	0.00464	CcSEcCtD
Diclofenac—Bromfenac—PTGS2—malignant glioma	0.000391	0.0948	CrCbGaD
Diclofenac—ALOX5—central nervous system—malignant glioma	0.000389	0.00563	CbGeAlD
Diclofenac—Pancytopenia—Carmustine—malignant glioma	0.000385	0.00453	CcSEcCtD
Diclofenac—Sweating increased—Temozolomide—malignant glioma	0.000381	0.00449	CcSEcCtD
Diclofenac—SLCO1C1—brain—malignant glioma	0.000381	0.00552	CbGeAlD
Diclofenac—ALOX5—cerebellum—malignant glioma	0.00038	0.00551	CbGeAlD
Diclofenac—Bronchitis—Temozolomide—malignant glioma	0.000377	0.00444	CcSEcCtD
Diclofenac—Pancytopenia—Temozolomide—malignant glioma	0.000372	0.00438	CcSEcCtD
Diclofenac—Dysuria—Temozolomide—malignant glioma	0.000366	0.00431	CcSEcCtD
Diclofenac—Hyperglycaemia—Carmustine—malignant glioma	0.000366	0.00431	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000364	0.00429	CcSEcCtD
Diclofenac—Pneumonia—Carmustine—malignant glioma	0.000363	0.00428	CcSEcCtD
Diclofenac—Pollakiuria—Temozolomide—malignant glioma	0.000362	0.00426	CcSEcCtD
Diclofenac—Erectile dysfunction—Temozolomide—malignant glioma	0.000361	0.00425	CcSEcCtD
Diclofenac—Depression—Carmustine—malignant glioma	0.00036	0.00424	CcSEcCtD
Diclofenac—Photosensitivity reaction—Temozolomide—malignant glioma	0.000357	0.00421	CcSEcCtD
Diclofenac—Weight increased—Temozolomide—malignant glioma	0.000356	0.0042	CcSEcCtD
Diclofenac—Renal failure—Carmustine—malignant glioma	0.000355	0.00418	CcSEcCtD
Diclofenac—Weight decreased—Temozolomide—malignant glioma	0.000354	0.00417	CcSEcCtD
Diclofenac—Neuropathy peripheral—Carmustine—malignant glioma	0.000354	0.00417	CcSEcCtD
Diclofenac—Hyperglycaemia—Temozolomide—malignant glioma	0.000353	0.00416	CcSEcCtD
Diclofenac—Stomatitis—Carmustine—malignant glioma	0.000352	0.00415	CcSEcCtD
Diclofenac—Mefenamic acid—PTGS1—malignant glioma	0.000352	0.0854	CrCbGaD
Diclofenac—Urinary tract infection—Carmustine—malignant glioma	0.000351	0.00414	CcSEcCtD
Diclofenac—Pneumonia—Temozolomide—malignant glioma	0.000351	0.00414	CcSEcCtD
Diclofenac—SCN4A—brain—malignant glioma	0.00035	0.00507	CbGeAlD
Diclofenac—Infestation NOS—Temozolomide—malignant glioma	0.000349	0.00411	CcSEcCtD
Diclofenac—Infestation—Temozolomide—malignant glioma	0.000349	0.00411	CcSEcCtD
Diclofenac—SLC22A6—brain—malignant glioma	0.000349	0.00505	CbGeAlD
Diclofenac—Depression—Temozolomide—malignant glioma	0.000348	0.0041	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000346	0.00408	CcSEcCtD
Diclofenac—Neuropathy peripheral—Temozolomide—malignant glioma	0.000342	0.00403	CcSEcCtD
Diclofenac—TTR—brain—malignant glioma	0.000341	0.00493	CbGeAlD
Diclofenac—Stomatitis—Temozolomide—malignant glioma	0.00034	0.00401	CcSEcCtD
Diclofenac—Urinary tract infection—Temozolomide—malignant glioma	0.000339	0.004	CcSEcCtD
Diclofenac—ABCB1—blood vessel—malignant glioma	0.000335	0.00485	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—malignant glioma	0.000332	0.0806	CrCbGaD
Diclofenac—Hepatobiliary disease—Temozolomide—malignant glioma	0.00033	0.00389	CcSEcCtD
Diclofenac—Sinusitis—Temozolomide—malignant glioma	0.000328	0.00386	CcSEcCtD
Diclofenac—Haemoglobin—Carmustine—malignant glioma	0.000326	0.00384	CcSEcCtD
Diclofenac—Haemorrhage—Carmustine—malignant glioma	0.000324	0.00382	CcSEcCtD
Diclofenac—PTGS2—embryo—malignant glioma	0.000323	0.00468	CbGeAlD
Diclofenac—Hypoaesthesia—Carmustine—malignant glioma	0.000323	0.0038	CcSEcCtD
Diclofenac—Hallucination—Carmustine—malignant glioma	0.000323	0.0038	CcSEcCtD
Diclofenac—Oedema peripheral—Carmustine—malignant glioma	0.00032	0.00376	CcSEcCtD
Diclofenac—Nepafenac—PTGS2—malignant glioma	0.000316	0.0767	CrCbGaD
Diclofenac—Haemoglobin—Temozolomide—malignant glioma	0.000315	0.00371	CcSEcCtD
Diclofenac—Haemorrhage—Temozolomide—malignant glioma	0.000313	0.00369	CcSEcCtD
Diclofenac—Hepatitis—Temozolomide—malignant glioma	0.000313	0.00369	CcSEcCtD
Diclofenac—Visual impairment—Carmustine—malignant glioma	0.000313	0.00368	CcSEcCtD
Diclofenac—Hallucination—Temozolomide—malignant glioma	0.000312	0.00367	CcSEcCtD
Diclofenac—Hypoaesthesia—Temozolomide—malignant glioma	0.000312	0.00367	CcSEcCtD
Diclofenac—Pharyngitis—Temozolomide—malignant glioma	0.000311	0.00366	CcSEcCtD
Diclofenac—Urinary tract disorder—Temozolomide—malignant glioma	0.00031	0.00365	CcSEcCtD
Diclofenac—Oedema peripheral—Temozolomide—malignant glioma	0.000309	0.00364	CcSEcCtD
Diclofenac—ALOX5—brain—malignant glioma	0.000309	0.00447	CbGeAlD
Diclofenac—Urethral disorder—Temozolomide—malignant glioma	0.000307	0.00362	CcSEcCtD
Diclofenac—Eye disorder—Carmustine—malignant glioma	0.000303	0.00357	CcSEcCtD
Diclofenac—Visual impairment—Temozolomide—malignant glioma	0.000302	0.00356	CcSEcCtD
Diclofenac—Flushing—Carmustine—malignant glioma	0.000301	0.00355	CcSEcCtD
Diclofenac—Erythema multiforme—Temozolomide—malignant glioma	0.000296	0.00349	CcSEcCtD
Diclofenac—Eye disorder—Temozolomide—malignant glioma	0.000293	0.00345	CcSEcCtD
Diclofenac—Tinnitus—Temozolomide—malignant glioma	0.000292	0.00344	CcSEcCtD
Diclofenac—Flushing—Temozolomide—malignant glioma	0.000291	0.00343	CcSEcCtD
Diclofenac—Cardiac disorder—Temozolomide—malignant glioma	0.000291	0.00343	CcSEcCtD
Diclofenac—Arrhythmia—Carmustine—malignant glioma	0.00029	0.00341	CcSEcCtD
Diclofenac—Alopecia—Carmustine—malignant glioma	0.000287	0.00338	CcSEcCtD
Diclofenac—CYP2E1—telencephalon—malignant glioma	0.000285	0.00413	CbGeAlD
Diclofenac—Angiopathy—Temozolomide—malignant glioma	0.000284	0.00335	CcSEcCtD
Diclofenac—Mental disorder—Carmustine—malignant glioma	0.000284	0.00335	CcSEcCtD
Diclofenac—Immune system disorder—Temozolomide—malignant glioma	0.000283	0.00333	CcSEcCtD
Diclofenac—Mediastinal disorder—Temozolomide—malignant glioma	0.000283	0.00333	CcSEcCtD
Diclofenac—Malnutrition—Carmustine—malignant glioma	0.000282	0.00333	CcSEcCtD
Diclofenac—Erythema—Carmustine—malignant glioma	0.000282	0.00333	CcSEcCtD
Diclofenac—Chills—Temozolomide—malignant glioma	0.000281	0.00331	CcSEcCtD
Diclofenac—Alopecia—Temozolomide—malignant glioma	0.000277	0.00326	CcSEcCtD
Diclofenac—Mental disorder—Temozolomide—malignant glioma	0.000275	0.00323	CcSEcCtD
Diclofenac—PTGS1—telencephalon—malignant glioma	0.000275	0.00398	CbGeAlD
Diclofenac—Back pain—Carmustine—malignant glioma	0.000273	0.00322	CcSEcCtD
Diclofenac—Erythema—Temozolomide—malignant glioma	0.000273	0.00321	CcSEcCtD
Diclofenac—Malnutrition—Temozolomide—malignant glioma	0.000273	0.00321	CcSEcCtD
Diclofenac—Dysgeusia—Temozolomide—malignant glioma	0.000267	0.00315	CcSEcCtD
Diclofenac—Vision blurred—Carmustine—malignant glioma	0.000266	0.00313	CcSEcCtD
Diclofenac—ABCC4—central nervous system—malignant glioma	0.000265	0.00384	CbGeAlD
Diclofenac—Tremor—Carmustine—malignant glioma	0.000265	0.00312	CcSEcCtD
Diclofenac—Back pain—Temozolomide—malignant glioma	0.000264	0.00311	CcSEcCtD
Diclofenac—SLC22A8—central nervous system—malignant glioma	0.000263	0.00381	CbGeAlD
Diclofenac—PTGS2—telencephalon—malignant glioma	0.000263	0.0038	CbGeAlD
Diclofenac—Anaemia—Carmustine—malignant glioma	0.000261	0.00307	CcSEcCtD
Diclofenac—Agitation—Carmustine—malignant glioma	0.00026	0.00306	CcSEcCtD
Diclofenac—Meclofenamic acid—PTGS2—malignant glioma	0.000259	0.0628	CrCbGaD
Diclofenac—Vision blurred—Temozolomide—malignant glioma	0.000257	0.00303	CcSEcCtD
Diclofenac—Tremor—Temozolomide—malignant glioma	0.000256	0.00301	CcSEcCtD
Diclofenac—Ill-defined disorder—Temozolomide—malignant glioma	0.000253	0.00298	CcSEcCtD
Diclofenac—Leukopenia—Carmustine—malignant glioma	0.000253	0.00298	CcSEcCtD
Diclofenac—Anaemia—Temozolomide—malignant glioma	0.000252	0.00297	CcSEcCtD
Diclofenac—Agitation—Temozolomide—malignant glioma	0.000251	0.00295	CcSEcCtD
Diclofenac—Angioedema—Temozolomide—malignant glioma	0.000249	0.00294	CcSEcCtD
Diclofenac—Malaise—Temozolomide—malignant glioma	0.000246	0.0029	CcSEcCtD
Diclofenac—Vertigo—Temozolomide—malignant glioma	0.000245	0.00289	CcSEcCtD
Diclofenac—Convulsion—Carmustine—malignant glioma	0.000245	0.00288	CcSEcCtD
Diclofenac—Leukopenia—Temozolomide—malignant glioma	0.000244	0.00288	CcSEcCtD
Diclofenac—Hypertension—Carmustine—malignant glioma	0.000244	0.00287	CcSEcCtD
Diclofenac—Palpitations—Temozolomide—malignant glioma	0.000241	0.00284	CcSEcCtD
Diclofenac—Chest pain—Carmustine—malignant glioma	0.00024	0.00283	CcSEcCtD
Diclofenac—Myalgia—Carmustine—malignant glioma	0.00024	0.00283	CcSEcCtD
Diclofenac—Anxiety—Carmustine—malignant glioma	0.00024	0.00282	CcSEcCtD
Diclofenac—Cough—Temozolomide—malignant glioma	0.000238	0.0028	CcSEcCtD
Diclofenac—Convulsion—Temozolomide—malignant glioma	0.000236	0.00278	CcSEcCtD
Diclofenac—Hypertension—Temozolomide—malignant glioma	0.000236	0.00277	CcSEcCtD
Diclofenac—Confusional state—Carmustine—malignant glioma	0.000232	0.00274	CcSEcCtD
Diclofenac—Myalgia—Temozolomide—malignant glioma	0.000232	0.00274	CcSEcCtD
Diclofenac—Arthralgia—Temozolomide—malignant glioma	0.000232	0.00274	CcSEcCtD
Diclofenac—Anxiety—Temozolomide—malignant glioma	0.000232	0.00273	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000231	0.00272	CcSEcCtD
Diclofenac—Oedema—Carmustine—malignant glioma	0.00023	0.00271	CcSEcCtD
Diclofenac—Discomfort—Temozolomide—malignant glioma	0.00023	0.0027	CcSEcCtD
Diclofenac—Infection—Carmustine—malignant glioma	0.000229	0.0027	CcSEcCtD
Diclofenac—Dry mouth—Temozolomide—malignant glioma	0.000227	0.00268	CcSEcCtD
Diclofenac—Thrombocytopenia—Carmustine—malignant glioma	0.000226	0.00266	CcSEcCtD
Diclofenac—Tachycardia—Carmustine—malignant glioma	0.000225	0.00265	CcSEcCtD
Diclofenac—Confusional state—Temozolomide—malignant glioma	0.000225	0.00264	CcSEcCtD
Diclofenac—CYP2E1—medulla oblongata—malignant glioma	0.000224	0.00324	CbGeAlD
Diclofenac—Anaphylactic shock—Temozolomide—malignant glioma	0.000223	0.00262	CcSEcCtD
Diclofenac—Oedema—Temozolomide—malignant glioma	0.000223	0.00262	CcSEcCtD
Diclofenac—Infection—Temozolomide—malignant glioma	0.000221	0.00261	CcSEcCtD
Diclofenac—ABCC1—cerebellum—malignant glioma	0.000221	0.0032	CbGeAlD
Diclofenac—Anorexia—Carmustine—malignant glioma	0.00022	0.00259	CcSEcCtD
Diclofenac—Nervous system disorder—Temozolomide—malignant glioma	0.000218	0.00257	CcSEcCtD
Diclofenac—Thrombocytopenia—Temozolomide—malignant glioma	0.000218	0.00257	CcSEcCtD
Diclofenac—ALB—brain—malignant glioma	0.000217	0.00315	CbGeAlD
Diclofenac—Skin disorder—Temozolomide—malignant glioma	0.000216	0.00255	CcSEcCtD
Diclofenac—Hypotension—Carmustine—malignant glioma	0.000215	0.00254	CcSEcCtD
Diclofenac—Hyperhidrosis—Temozolomide—malignant glioma	0.000215	0.00254	CcSEcCtD
Diclofenac—Anorexia—Temozolomide—malignant glioma	0.000212	0.0025	CcSEcCtD
Diclofenac—ABCC4—brain—malignant glioma	0.00021	0.00305	CbGeAlD
Diclofenac—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00021	0.00247	CcSEcCtD
Diclofenac—SLC22A8—brain—malignant glioma	0.000209	0.00302	CbGeAlD
Diclofenac—Insomnia—Carmustine—malignant glioma	0.000208	0.00245	CcSEcCtD
Diclofenac—Paraesthesia—Carmustine—malignant glioma	0.000207	0.00244	CcSEcCtD
Diclofenac—PTGS2—medulla oblongata—malignant glioma	0.000206	0.00299	CbGeAlD
Diclofenac—Dyspnoea—Carmustine—malignant glioma	0.000205	0.00242	CcSEcCtD
Diclofenac—Somnolence—Carmustine—malignant glioma	0.000205	0.00241	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000203	0.00239	CcSEcCtD
Diclofenac—Insomnia—Temozolomide—malignant glioma	0.000201	0.00237	CcSEcCtD
Diclofenac—Mefenamic acid—PTGS2—malignant glioma	0.000201	0.0488	CrCbGaD
Diclofenac—Decreased appetite—Carmustine—malignant glioma	0.0002	0.00236	CcSEcCtD
Diclofenac—Paraesthesia—Temozolomide—malignant glioma	0.0002	0.00236	CcSEcCtD
Diclofenac—CYP2E1—spinal cord—malignant glioma	0.0002	0.00289	CbGeAlD
Diclofenac—ABCB1—embryo—malignant glioma	0.0002	0.00289	CbGeAlD
Diclofenac—Gastrointestinal disorder—Carmustine—malignant glioma	0.000199	0.00234	CcSEcCtD
Diclofenac—Dyspnoea—Temozolomide—malignant glioma	0.000199	0.00234	CcSEcCtD
Diclofenac—Somnolence—Temozolomide—malignant glioma	0.000198	0.00233	CcSEcCtD
Diclofenac—Pain—Carmustine—malignant glioma	0.000197	0.00232	CcSEcCtD
Diclofenac—Constipation—Carmustine—malignant glioma	0.000197	0.00232	CcSEcCtD
Diclofenac—Dyspepsia—Temozolomide—malignant glioma	0.000196	0.00231	CcSEcCtD
Diclofenac—Decreased appetite—Temozolomide—malignant glioma	0.000194	0.00228	CcSEcCtD
Diclofenac—PTGS1—spinal cord—malignant glioma	0.000192	0.00279	CbGeAlD
Diclofenac—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000192	0.00226	CcSEcCtD
Diclofenac—Fatigue—Temozolomide—malignant glioma	0.000192	0.00226	CcSEcCtD
Diclofenac—Pain—Temozolomide—malignant glioma	0.00019	0.00224	CcSEcCtD
Diclofenac—Constipation—Temozolomide—malignant glioma	0.00019	0.00224	CcSEcCtD
Diclofenac—Feeling abnormal—Carmustine—malignant glioma	0.00019	0.00224	CcSEcCtD
Diclofenac—PTGS2—midbrain—malignant glioma	0.000189	0.00273	CbGeAlD
Diclofenac—Gastrointestinal pain—Carmustine—malignant glioma	0.000188	0.00222	CcSEcCtD
Diclofenac—PTGS2—spinal cord—malignant glioma	0.000184	0.00266	CbGeAlD
Diclofenac—Feeling abnormal—Temozolomide—malignant glioma	0.000184	0.00216	CcSEcCtD
Diclofenac—Abdominal pain—Carmustine—malignant glioma	0.000182	0.00215	CcSEcCtD
Diclofenac—Body temperature increased—Carmustine—malignant glioma	0.000182	0.00215	CcSEcCtD
Diclofenac—Gastrointestinal pain—Temozolomide—malignant glioma	0.000182	0.00214	CcSEcCtD
Diclofenac—ABCC1—brain—malignant glioma	0.000179	0.0026	CbGeAlD
Diclofenac—CYP1A1—central nervous system—malignant glioma	0.000178	0.00257	CbGeAlD
Diclofenac—Urticaria—Temozolomide—malignant glioma	0.000177	0.00208	CcSEcCtD
Diclofenac—ABCB1—retina—malignant glioma	0.000177	0.00256	CbGeAlD
Diclofenac—Abdominal pain—Temozolomide—malignant glioma	0.000176	0.00207	CcSEcCtD
Diclofenac—Body temperature increased—Temozolomide—malignant glioma	0.000176	0.00207	CcSEcCtD
Diclofenac—CYP2B6—central nervous system—malignant glioma	0.000173	0.0025	CbGeAlD
Diclofenac—Hypersensitivity—Carmustine—malignant glioma	0.00017	0.002	CcSEcCtD
Diclofenac—Asthenia—Carmustine—malignant glioma	0.000165	0.00195	CcSEcCtD
Diclofenac—Hypersensitivity—Temozolomide—malignant glioma	0.000164	0.00193	CcSEcCtD
Diclofenac—ABCB1—telencephalon—malignant glioma	0.000162	0.00235	CbGeAlD
Diclofenac—CYP2E1—central nervous system—malignant glioma	0.000162	0.00235	CbGeAlD
Diclofenac—Asthenia—Temozolomide—malignant glioma	0.00016	0.00188	CcSEcCtD
Diclofenac—CYP2E1—cerebellum—malignant glioma	0.000158	0.00229	CbGeAlD
Diclofenac—Diarrhoea—Carmustine—malignant glioma	0.000158	0.00186	CcSEcCtD
Diclofenac—Pruritus—Temozolomide—malignant glioma	0.000158	0.00186	CcSEcCtD
Diclofenac—PTGS1—central nervous system—malignant glioma	0.000156	0.00226	CbGeAlD
Diclofenac—CYP2C8—brain—malignant glioma	0.000153	0.00221	CbGeAlD
Diclofenac—Dizziness—Carmustine—malignant glioma	0.000152	0.00179	CcSEcCtD
Diclofenac—Diarrhoea—Temozolomide—malignant glioma	0.000152	0.00179	CcSEcCtD
Diclofenac—PTGS2—central nervous system—malignant glioma	0.000149	0.00216	CbGeAlD
Diclofenac—Dizziness—Temozolomide—malignant glioma	0.000147	0.00173	CcSEcCtD
Diclofenac—Vomiting—Carmustine—malignant glioma	0.000147	0.00173	CcSEcCtD
Diclofenac—PTGS2—cerebellum—malignant glioma	0.000146	0.00211	CbGeAlD
Diclofenac—Rash—Carmustine—malignant glioma	0.000145	0.00171	CcSEcCtD
Diclofenac—Dermatitis—Carmustine—malignant glioma	0.000145	0.00171	CcSEcCtD
Diclofenac—Headache—Carmustine—malignant glioma	0.000144	0.0017	CcSEcCtD
Diclofenac—Vomiting—Temozolomide—malignant glioma	0.000142	0.00167	CcSEcCtD
Diclofenac—CYP1A1—brain—malignant glioma	0.000141	0.00204	CbGeAlD
Diclofenac—Rash—Temozolomide—malignant glioma	0.00014	0.00165	CcSEcCtD
Diclofenac—Dermatitis—Temozolomide—malignant glioma	0.00014	0.00165	CcSEcCtD
Diclofenac—Headache—Temozolomide—malignant glioma	0.00014	0.00164	CcSEcCtD
Diclofenac—CYP2B6—brain—malignant glioma	0.000137	0.00199	CbGeAlD
Diclofenac—Nausea—Carmustine—malignant glioma	0.000137	0.00161	CcSEcCtD
Diclofenac—Nausea—Temozolomide—malignant glioma	0.000132	0.00156	CcSEcCtD
Diclofenac—CYP3A4—central nervous system—malignant glioma	0.00013	0.00189	CbGeAlD
Diclofenac—CYP2E1—brain—malignant glioma	0.000129	0.00186	CbGeAlD
Diclofenac—ABCB1—medulla oblongata—malignant glioma	0.000128	0.00185	CbGeAlD
Diclofenac—PTGS1—brain—malignant glioma	0.000124	0.00179	CbGeAlD
Diclofenac—PTGS2—brain—malignant glioma	0.000118	0.00172	CbGeAlD
Diclofenac—ABCB1—midbrain—malignant glioma	0.000117	0.00169	CbGeAlD
Diclofenac—ABCB1—spinal cord—malignant glioma	0.000114	0.00165	CbGeAlD
Diclofenac—ABCB1—central nervous system—malignant glioma	9.23e-05	0.00134	CbGeAlD
Diclofenac—ABCB1—cerebellum—malignant glioma	9.02e-05	0.00131	CbGeAlD
Diclofenac—ABCB1—brain—malignant glioma	7.33e-05	0.00106	CbGeAlD
Diclofenac—ALOX5—Metabolism—PIK3CA—malignant glioma	4.42e-06	3.69e-05	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	4.41e-06	3.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HIF1A—malignant glioma	4.41e-06	3.68e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—malignant glioma	4.4e-06	3.67e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NCOR1—malignant glioma	4.38e-06	3.66e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP3—malignant glioma	4.38e-06	3.65e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL2—malignant glioma	4.37e-06	3.65e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CAT—malignant glioma	4.37e-06	3.65e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—BCHE—malignant glioma	4.35e-06	3.63e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—malignant glioma	4.33e-06	3.61e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC5A5—malignant glioma	4.3e-06	3.59e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.3e-06	3.59e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.3e-06	3.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.29e-06	3.58e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS1—malignant glioma	4.27e-06	3.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CAV1—malignant glioma	4.27e-06	3.56e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CD—malignant glioma	4.26e-06	3.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.26e-06	3.55e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—BCHE—malignant glioma	4.25e-06	3.55e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTP1—malignant glioma	4.23e-06	3.53e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NCOR1—malignant glioma	4.21e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTEN—malignant glioma	4.21e-06	3.52e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC5A5—malignant glioma	4.2e-06	3.5e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—malignant glioma	4.19e-06	3.49e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—malignant glioma	4.14e-06	3.45e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.14e-06	3.45e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NCOR1—malignant glioma	4.13e-06	3.44e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAT—malignant glioma	4.12e-06	3.44e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTEN—malignant glioma	4.11e-06	3.43e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CG—malignant glioma	4.1e-06	3.42e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTEN—malignant glioma	4.1e-06	3.42e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.07e-06	3.39e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.03e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—malignant glioma	4.01e-06	3.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BAD—malignant glioma	4.01e-06	3.35e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.99e-06	3.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOTCH1—malignant glioma	3.97e-06	3.32e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—BCHE—malignant glioma	3.97e-06	3.31e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—malignant glioma	3.96e-06	3.3e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.94e-06	3.29e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.92e-06	3.27e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—IDH1—malignant glioma	3.92e-06	3.27e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.92e-06	3.27e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTT1—malignant glioma	3.89e-06	3.25e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD80—malignant glioma	3.89e-06	3.25e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NCOR1—malignant glioma	3.89e-06	3.25e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—malignant glioma	3.89e-06	3.24e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—malignant glioma	3.88e-06	3.24e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—malignant glioma	3.88e-06	3.24e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.87e-06	3.23e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—malignant glioma	3.86e-06	3.22e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CB—malignant glioma	3.85e-06	3.22e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGF—malignant glioma	3.84e-06	3.21e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—malignant glioma	3.83e-06	3.2e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—malignant glioma	3.82e-06	3.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTPN11—malignant glioma	3.82e-06	3.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SPHK1—malignant glioma	3.79e-06	3.17e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAT—malignant glioma	3.78e-06	3.15e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAT—malignant glioma	3.76e-06	3.13e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CB—malignant glioma	3.72e-06	3.1e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.72e-06	3.1e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—malignant glioma	3.72e-06	3.1e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.71e-06	3.09e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—malignant glioma	3.68e-06	3.07e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—malignant glioma	3.68e-06	3.07e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.68e-06	3.07e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—malignant glioma	3.65e-06	3.05e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS1—malignant glioma	3.65e-06	3.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.64e-06	3.03e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—malignant glioma	3.61e-06	3.01e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CD—malignant glioma	3.6e-06	3.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CAV1—malignant glioma	3.57e-06	2.98e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NCOR1—malignant glioma	3.57e-06	2.98e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT2—malignant glioma	3.56e-06	2.97e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NCOR1—malignant glioma	3.55e-06	2.96e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—malignant glioma	3.54e-06	2.95e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.51e-06	2.93e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—malignant glioma	3.46e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CAV1—malignant glioma	3.43e-06	2.87e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—malignant glioma	3.43e-06	2.86e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—malignant glioma	3.42e-06	2.85e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CD—malignant glioma	3.42e-06	2.85e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.41e-06	2.85e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—BCHE—malignant glioma	3.39e-06	2.83e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—malignant glioma	3.38e-06	2.82e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAT—malignant glioma	3.37e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CAV1—malignant glioma	3.36e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.35e-06	2.8e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—malignant glioma	3.34e-06	2.79e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—malignant glioma	3.33e-06	2.78e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—malignant glioma	3.3e-06	2.76e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAT—malignant glioma	3.29e-06	2.75e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FGF2—malignant glioma	3.27e-06	2.73e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—malignant glioma	3.26e-06	2.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—malignant glioma	3.21e-06	2.68e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.21e-06	2.67e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—malignant glioma	3.19e-06	2.66e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NCOR1—malignant glioma	3.18e-06	2.66e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAV1—malignant glioma	3.17e-06	2.65e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.17e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—malignant glioma	3.16e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—malignant glioma	3.16e-06	2.64e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—malignant glioma	3.14e-06	2.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—malignant glioma	3.14e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.14e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—malignant glioma	3.13e-06	2.61e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—malignant glioma	3.12e-06	2.6e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—malignant glioma	3.11e-06	2.6e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NCOR1—malignant glioma	3.11e-06	2.59e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAT—malignant glioma	3.07e-06	2.56e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—malignant glioma	3.06e-06	2.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—malignant glioma	3.06e-06	2.55e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAF1—malignant glioma	3.05e-06	2.55e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—malignant glioma	3.03e-06	2.53e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.03e-06	2.53e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—malignant glioma	3.02e-06	2.52e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—malignant glioma	3.02e-06	2.52e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—malignant glioma	3.01e-06	2.51e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—malignant glioma	2.98e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—malignant glioma	2.97e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—malignant glioma	2.96e-06	2.47e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—malignant glioma	2.94e-06	2.46e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—malignant glioma	2.94e-06	2.45e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAV1—malignant glioma	2.91e-06	2.43e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NCOR1—malignant glioma	2.9e-06	2.42e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—malignant glioma	2.9e-06	2.42e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—malignant glioma	2.89e-06	2.41e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAV1—malignant glioma	2.89e-06	2.41e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.89e-06	2.41e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—malignant glioma	2.86e-06	2.39e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS1—malignant glioma	2.82e-06	2.35e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—malignant glioma	2.81e-06	2.34e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—malignant glioma	2.79e-06	2.33e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.78e-06	2.32e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.76e-06	2.3e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—malignant glioma	2.75e-06	2.29e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.74e-06	2.28e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—malignant glioma	2.72e-06	2.27e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—malignant glioma	2.71e-06	2.26e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—malignant glioma	2.7e-06	2.25e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—malignant glioma	2.69e-06	2.25e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.65e-06	2.21e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—malignant glioma	2.63e-06	2.2e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAT—malignant glioma	2.63e-06	2.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—BCHE—malignant glioma	2.62e-06	2.18e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAV1—malignant glioma	2.6e-06	2.17e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.59e-06	2.16e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—malignant glioma	2.57e-06	2.15e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—malignant glioma	2.56e-06	2.13e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—malignant glioma	2.54e-06	2.12e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—malignant glioma	2.54e-06	2.12e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAV1—malignant glioma	2.53e-06	2.11e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—malignant glioma	2.49e-06	2.08e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NCOR1—malignant glioma	2.48e-06	2.07e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.48e-06	2.07e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—malignant glioma	2.48e-06	2.07e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—malignant glioma	2.43e-06	2.03e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—malignant glioma	2.4e-06	2e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—malignant glioma	2.38e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—malignant glioma	2.37e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAV1—malignant glioma	2.37e-06	1.97e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.36e-06	1.97e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—malignant glioma	2.36e-06	1.97e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—malignant glioma	2.35e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—malignant glioma	2.35e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.33e-06	1.94e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—malignant glioma	2.33e-06	1.94e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—malignant glioma	2.32e-06	1.93e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—malignant glioma	2.31e-06	1.93e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—malignant glioma	2.3e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—malignant glioma	2.28e-06	1.9e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—malignant glioma	2.27e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.26e-06	1.89e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—malignant glioma	2.23e-06	1.86e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—malignant glioma	2.21e-06	1.85e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—malignant glioma	2.21e-06	1.84e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—malignant glioma	2.19e-06	1.83e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.16e-06	1.8e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—malignant glioma	2.16e-06	1.8e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—malignant glioma	2.14e-06	1.78e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—malignant glioma	2.09e-06	1.75e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—malignant glioma	2.08e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—malignant glioma	2.08e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.08e-06	1.73e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—malignant glioma	2.07e-06	1.73e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.03e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—malignant glioma	2.03e-06	1.69e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—malignant glioma	2.03e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAT—malignant glioma	2.03e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAV1—malignant glioma	2.02e-06	1.69e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—malignant glioma	2.02e-06	1.68e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—malignant glioma	2.01e-06	1.68e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—malignant glioma	2e-06	1.67e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—malignant glioma	1.98e-06	1.65e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.93e-06	1.61e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—malignant glioma	1.92e-06	1.6e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—malignant glioma	1.92e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOR1—malignant glioma	1.91e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—malignant glioma	1.91e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.9e-06	1.58e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—malignant glioma	1.85e-06	1.54e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.84e-06	1.54e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—malignant glioma	1.82e-06	1.51e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.81e-06	1.51e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—malignant glioma	1.79e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—malignant glioma	1.78e-06	1.48e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—malignant glioma	1.77e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—malignant glioma	1.75e-06	1.46e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—malignant glioma	1.75e-06	1.46e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—malignant glioma	1.74e-06	1.45e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.65e-06	1.38e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—malignant glioma	1.64e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.62e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—malignant glioma	1.57e-06	1.31e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—malignant glioma	1.56e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAV1—malignant glioma	1.56e-06	1.3e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—malignant glioma	1.53e-06	1.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—malignant glioma	1.52e-06	1.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—malignant glioma	1.48e-06	1.24e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—malignant glioma	1.46e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.43e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—malignant glioma	1.43e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.42e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.41e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—malignant glioma	1.4e-06	1.17e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—malignant glioma	1.37e-06	1.14e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.35e-06	1.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.25e-06	1.04e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—malignant glioma	1.24e-06	1.04e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.24e-06	1.03e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—malignant glioma	1.23e-06	1.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—malignant glioma	1.22e-06	1.02e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—malignant glioma	1.19e-06	9.96e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—malignant glioma	1.17e-06	9.76e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.1e-06	9.21e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—malignant glioma	1.1e-06	9.2e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.09e-06	9.09e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—malignant glioma	1.08e-06	9.01e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—malignant glioma	1.08e-06	8.99e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—malignant glioma	1.01e-06	8.43e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.01e-06	8.4e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—malignant glioma	1e-06	8.38e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—malignant glioma	9.41e-07	7.85e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—malignant glioma	9.02e-07	7.53e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—malignant glioma	8.81e-07	7.35e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—malignant glioma	8.6e-07	7.18e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—malignant glioma	8.23e-07	6.86e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—malignant glioma	7.03e-07	5.86e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.64e-07	5.54e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—malignant glioma	5.43e-07	4.53e-06	CbGpPWpGaD
